Skip to main content
. 2018 Sep 11;14:1691–1700. doi: 10.2147/TCRM.S173041

Figure 5.

Figure 5

Kaplan–Meier estimates of progression-free survival and overall survival times.

Notes: (A) Kaplan–Meier plots of progression-free survival in the full analytical set of patients with advanced pancreatic cancer who received the PD-1/PD-L1 inhibitor in monotherapy and combined therapy. (B) Kaplan–Meier plots of overall survival times in the full analytical set of patients with advanced pancreatic cancer who received the PD-1/PD-L1 inhibitor in monotherapy and combined therapy.